Remdesivir On Way To Approval
First new treatment for Covid-19 looks likely for speedy approval
Other Voices: 3 Covid-19 Investments For Consideration
Investors Alley's Eddy Elfenbein highlights three drug plays that could benefit from the Covid-19 Outbreak
Other Voices: Big Money In Uranium?
Investors Alley's Jay Soloff discusses a huge option play on a uranium concern
How Much Is Amazon Really Worth?
A 'sum of the parts' analysis and valuation of Amazon is provided in the paragraphs below
TOP STORIES
Other Voices: Will Semiconductors Soar In 2020?
Investors Alley's Jay Soloff talks about the semiconductor space in 2020 and one possible trade on AMD
Other Voices: A Biotech 'Lottery Ticket'
Investors Alley Eddy Elfenbein explains why he prefers one tech workhorse to a current biotech 'lottery ticket'
Other Voices: Why This Small Cap Stock Will Keep On Trucking In 2020
Investors Alley's Jay Soloff highlights a bullish bet on a small cap transportation concern
Other Voices: Why Fate Therapeutics Could Continue To Move Higher
Investor's Alley Ian Cooper discusses why the big rally in Fate Therapeutics may continue in 2020
Other Voices: Which Way For Interest Rates In 2020?
Options Expert Jay Soloff takes a look at the direction of interest rates in 2020 and one option trade around that
Other Voices: Time To 'Ring The Register' On 3 Healthcare Stocks
Investors Alley Eddy Elfenbein has three healthcare stocks that should be sold immediately due to overvaluation
Other Voices: Will The Market Crack Again This December?
Options expert Jay Soloff examines how one trader is positioning for another market crack this December
Natural Gas Price About To Pop?
Options Expert Jay Soloff highlights an option strategy to profit if cold weather pushes natural gas prices higher
T2 Biosystems: To The Moon?
We take a look at the wild ride in T2 Biosytems and how to play this $2.50 medical diagnostic stock
2017 Redux?
Investors Alley's Jay Soloff considers the possibility that volatility may wane in near term future
A Sucker Born Every Minute
Investors Alley Eddy Elfenbein discusses a 22 year old frat boy ponzi schemer and why he likes Aflac below
Behind The Recent Rebound In Ocular Therapeutix
The stock of Ocular Therapeutix is starting to rebound. We discuss some quick reasons for the new strength below
The Bet On Rising Gold Prices
Other Voices: Options Expert Jay Soloff describes a solid option bet on rising gold prices
Are You Ready For Cannabis 2.0?
Other Voices: Eddy Elfenbein on the 'second wave' of cannabis products and investing
Some Quick Thoughts On Flexion Therapeutics
Some quick thoughts on what yesterday's FDA action means for shareholders of Flexion Therapeutics
Other Voices: Webinar/Last Chance
Your time is running out for a 6-figure income (1:00 PM eastern deadline!)